Prevalence of switching from brand to generic asthma medications

Marjolein Engelkes (Bergschenhoek, Netherlands), Marjolein Engelkes, Nico Van Blijderveen, Katia Verhamme, Jetty Overbeek, Josine Kuiper, Ron Herings, Miriam Sturkenboom, Johan De Jongste, Hettie Janssens

Source: International Congress 2015 – Treatment and control of respiratory disease
Session: Treatment and control of respiratory disease
Session type: Thematic Poster Session
Number: 4057
Disease area: Airway diseases, Paediatric lung diseases

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Marjolein Engelkes (Bergschenhoek, Netherlands), Marjolein Engelkes, Nico Van Blijderveen, Katia Verhamme, Jetty Overbeek, Josine Kuiper, Ron Herings, Miriam Sturkenboom, Johan De Jongste, Hettie Janssens. Prevalence of switching from brand to generic asthma medications. Eur Respir J 2015; 46: Suppl. 59, 4057

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
The use and abuse of steroids in asthma action plans
Source: International Congress 2015 – Any news from the asthma field?
Year: 2015



Consumption of asthma and allergy drugs in Finland
Source: International Congress 2016 – Asthma management
Year: 2016


An overview of patient adherence to asthma medication in Canada
Source: Annual Congress 2013 –Treatment and adherence to treatment of respiratory disease
Year: 2013

Global asthma network identifies gaps in essential asthma medicines
Source: International Congress 2016 – Clinical studies in asthma and immunology
Year: 2016

Adherence to asthma medication and preferences for once-daily treatment: Importance of treatment intrusiveness and patient beliefs
Source: International Congress 2016 – Notable abstracts on clinical problems related to asthma
Year: 2016


Effectiveness of montelukast on asthma control in infants: A claims data study
Source: International Congress 2015 – Treatment and control of respiratory disease
Year: 2015


Management and interventions for asthma: Collaboration in action
Source: Annual Congress 2013 –Asthma treatment and management in children
Year: 2013


A national database study of the effectiveness of switching real-life asthma patients to fostair
Source: International Congress 2015 – New data on established treatments for asthma, COPD and bronchiectasis
Year: 2015


Barriers to adherence to asthma medication
Source: International Congress 2015 – Immune aspects of asthma and other airway diseases
Year: 2015


Global asthma network survey of national asthma strategies – Where are the gaps?
Source: International Congress 2016 – Clinical studies in asthma and immunology
Year: 2016

Real-life asthma impairment: SABA use depends on smoking phenotype
Source: Annual Congress 2013 –Treatment and management of asthma in primary care
Year: 2013


Current and future costs of asthma in the Netherlands
Source: Annual Congress 2013 –Health economics of airway diseases
Year: 2013

Prescription patterns and treatment adherence of asthma controller therapy in children in a Dutch primary care database
Source: Annual Congress 2013 –Paediatric respiratory epidemiology: bronchiolitis and asthma
Year: 2013


Non-adherence to asthma medications: Relation to socio-economic status and asthma education
Source: International Congress 2015 – Management of asthma and COPD in primary care
Year: 2015



Pattern of asthma control and inhaled corticosteroid (ICS) use in an Australian asthma population
Source: Annual Congress 2013 –Treatment and adherence to treatment of respiratory disease
Year: 2013


Investigation for asthma-related healthcare utilization and prescription of pregnant women with asthma in Korea
Source: Annual Congress 2013 –Epidemiology of asthma
Year: 2013

Asthma severity, poor control, co-morbidities and prior resource use determined omalizumab prescriptions in a nested case-control study with US claims data
Source: International Congress 2015 – Clincal aspects of asthma: monitoring and mechanisms
Year: 2015


Prevalence of asthma and management of exacerbations in general practice (GP) after computerised Spanish guideline on the management of asthma (GEMA) and collaborative care environment
Source: International Congress 2015 – Management of asthma and COPD in primary care
Year: 2015


Asthma severity and medical resource utilisation
Source: Eur Respir J 2004; 23: 723-729
Year: 2004



Inappropriate asthma therapy: A tale of two countries
Source: International Congress 2016 – Asthma: treatment, disease control, and quality of life
Year: 2016